Google
LIVN Stock Analysis — LIVANOVA PLC (Healthcare >> Medical Devices)
LIVN FAQ
What is LIVN's P/E ratio?
LIVANOVA PLC (LIVN) currently trades at a P/E ratio of 41.56.
What is LIVN's ROE?
LIVANOVA PLC reports a Return on Equity (ROE) of 8.84%.
What is LIVN's dividend yield?
LIVANOVA PLC offers a dividend yield of 0.00%.
What is LIVN's Quality Score?
Our AI rates LIVN's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy LIVN?
Our AI Timing Score for LIVN is 89 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does LIVN belong to?
LIVANOVA PLC is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange
LIVN AI Analysis Summary
Our AI summary for LIVN: LIVANOVA PLC (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 41.56, ROE of 8.84%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 80.14
Price
-0.91
(-1.12%)
Day Change
|
|
|---|
LIVN, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Quality Factors |
|
39% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 97 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 80.14 |
| PBV / Sector |
3.68 / -101.57
|
| Earning Per Share | 1.93 |
| PE / Sector |
41.56 / 31.23
|
| PEG or PE/Growth / Sector |
-0.36 / 0.40
|
| Average 1M Daily Value |
43.73 M
GREAT
|
| Average 1W Daily Value |
42.09 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
50% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-01 08:00:07 |
| Symbol | LIVN |
| Name | LIVANOVA PLC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 54.93 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 4,452.36 / 20,104.97 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 5220 Valiant Court, Gloucester, United Kingdom, GL3 4FE
Phone: 44 1452 638 500
Website: https://www.livanova.com
Employees: 3,300
Sector: Healthcare >> Medical Devices
Description: LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
